3171 results for «3304»

Filter By

3171 results

TAVI: technical considerations

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...

TAVI: technical considerations

Challenging scenarios: bioprosthetic valve dysfunction

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...

Challenging scenarios: bioprosthetic valve dysfunction

TAVI complications: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover how to manage various TAVI complications: complex iliofemoral artery dissection following TAVI, ruptured TAVI balloon, displacement of the transcatheter aortic valve prosthesis, and much more!

TAVI complications: Session 3

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

28 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

Rapid-fire abstracts: Session 5

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of right ventricular dysfunction on the outcomes of TAVI - Insights from nationwide database, impact of COVID-19 pandemic on TAVI activity: a worldwide registry, redo isolated tricuspid valve surgery - Prediction of...

Rapid-fire abstracts: Session 5

Rapid-Fire clinical cases: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!

Rapid-Fire clinical cases: Session 3

Transcatheter mitral valve interventions: clinical outcomes 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...

Transcatheter mitral valve interventions: clinical outcomes 1

Rapid-fire abstracts: Session 6

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...

Rapid-fire abstracts: Session 6

Rapid-fire abstracts: Session 7

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...

Rapid-fire abstracts: Session 7

Rapid-fire clinical cases: Session 4

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...

Rapid-fire clinical cases: Session 4

Rapid-fire abstracts: Session 8

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...

Rapid-fire abstracts: Session 8

A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring

28 Nov 2022 – From PCR London Valves 2022

Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.

A case-based tailored

Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management

28 Nov 2022 – From PCR London Valves 2022

Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.

Haemodynamic performance

Tricuspid valve intervention - Get it right!

29 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to learn tips and tricks that influence procedural strategy through a real-life case as well as anatomical factors that contribute to tricuspid valve complexity and choice of treatment, followed by the latest clinical data.

Tricuspid valve intervention

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

27 Nov 2022 – From PCR London Valves 2022

In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

Maintaining selective coronary access after TAVI and re-do TAVI procedures

28 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.

Maintaining selective

Optimising immediate and long-term outcomes after TAVI

29 Nov 2022 – From PCR London Valves 2022

This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.

Optimising immediate

Twenty years of progress - What we have achieved - LIVE case

27 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI by axillary access (Live)
    An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
    The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Twenty years of progress - What we have achieved

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Therapy of valvular heart diseases: a patient-centred innovation journey

27 Nov 2022 – From PCR London Valves 2022

Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.

Therapy of valvular heart
Didn’t find what you were looking for?